<DOC>
	<DOCNO>NCT00975715</DOCNO>
	<brief_summary>This study design provide short term efficacy safety data TRI476 child inadequately-controlled partial seizure . Patients randomize either drug treatment placebo group 1:1 ratio , receive respective treatment 8 week . The purpose study confirm TRI476 adjunctive therapy effective safe .</brief_summary>
	<brief_title>Efficacy , Safety Tolerability TRI476 ( Oxcarbazepine ) Children With Inadequately Controlled Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Male female outpatient , age 4 14 year ( inclusive ) , minimum body weight 15 kg . A diagnosis partial onset seizure , include seizure subtypes simple , complex , secondarily generalize seizure ( base International League Against Epilepsy ( ILAE ) Classification , modify 1981 ) . A document history generalize status epileptic past 6 month . Seizures metabolic , neoplastic , active infectious origin . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Seizures</keyword>
	<keyword>oxcarbazepine</keyword>
	<keyword>child</keyword>
</DOC>